ASHTON HOUDE: Open Payments
NPI 1720605124 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,309 in 64 payments from 13 companies in 2025. Trend: 2023 $841 · 2024 $872 · 2025 $1,309
Food & beverage: $1,309
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $383 |
| Otsuka America Pharmaceutical, Inc. | 22 | $308 |
| ABBVIE INC. | 8 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $105 |
| Janssen Pharmaceuticals, Inc | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| Alkermes, Inc. | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Corium, LLC | 1 | $29 |
Products named: COBENFY, REXULTI, VRAYLAR, CAPLYTA, INVEGA SUSTENNA, FANAPT, Qelbree, ARISTADA.
Industry payments across MA — which companies pay providers there.
